• 제목/요약/키워드: hematological examination

검색결과 162건 처리시간 0.019초

랫드에서 CONP01에 대한 4주 반복투여 독성연구 (Four-Week Repeated-Dose Toxicity Studies of CONP01 in Rats)

  • 홍동호;장호송;김광호;길기현;김재민;한명규;배진숙;김남두;이현걸;이정숙;이선경;박찬구;송시환
    • Toxicological Research
    • /
    • 제20권4호
    • /
    • pp.349-357
    • /
    • 2004
  • This study was performed to evaluate repeated-dose toxicities of CONP01 in Sprague-Dawley rats. CONP01, a new antiarthritic agent was administered orally to rats at dose levels of 0, 125, 500 and 2,000 mg/kg/day for 4 weeks. In present study, there were no dose response changes in mortality, clinical signs, body weight changes, food and water consumption, ophthalmoscopy, organ weights, urine analysis, hematological findings, and biochemical examination of all animals treated with CONP01. Gross and histopathological findings revealed no evidence of specific toxicity related to CONP01. These result suggest that no observed adverse effect level (NOAEL) of CONP01 may be over 2,000 mg/kg in rats.

FOUR-WEEK REPEATED INTRAMUSCULAR TOXICITY STUDIES OF A NEW TSUTSUGAMUSm VACCINE, MBRI-98305R IN BEAGLE DOGS

  • Ji, Hyeong-Jin;Roh,Yong-Woo;Sin, Ji-Soon;Jung, Eun-Yong;Zhang, Hu-Song;Huang, Zai-Zhi;Zheng, Mei-Shu;Choi, Ehn-Kyung;Kim, Dae-Joon;Kang, Jong-Koo
    • 한국독성학회:학술대회논문집
    • /
    • 한국독성학회 2001년도 International Symposium on Dietary and Medicinal Antimutgens and Anticarcinogens
    • /
    • pp.171-171
    • /
    • 2001
  • This study was designed to evaluate a repeated dose toxicity of a new tsutsugamushi vaccine, MBRI-98305R in 4-month-old beagle dogs. Animals were intramuscularly injected with dosages of 283, 56.6, 14.15 and 0 $\mu\textrm{g}$/kg everyday for 4 weeks, respectively. There were no dose-related statistical significant changes in clinical signs, body weight changes, food or water consumption, opthalmoscopy, hematological findings and biochemical examination of all animals treated with MBRI-98305R.(omitted)

  • PDF

Immunomodulatory effects of silymarin after subacute exposure to mice: A tiered approach immunotoxicity screening

  • Karimi, Gholamreza;Hassanzadeh-Josan, Samed;Memar, Bahram;Esmaeili, Seyed-Alireza;Riahi-Zanjani, Bamdad
    • 대한약침학회지
    • /
    • 제21권2호
    • /
    • pp.90-97
    • /
    • 2018
  • Silymarin is a flavonoid complex extracted from the Silybum marianum plant with a wide range of pharmacological and biochemical effects. In the present study, the immunomodulatory effects of silymarin were investigated in BALB/c mice. Silymarin was administered daily by intraperitoneal injection at doses of 50, 100 and 150 mg/kg for 14 consecutive days. Following the exposure, host hematological parameters, spleen cellularity and histopathological examination, as well as delayed-type hypersensitivity (DTH) responses, hemagglutination titers (HA), splenocyte cytokine production and lymphocyte proliferation assay were studied in all of the test groups of animals. The results showed that the low dose of silymarin (50 mg/kg) could stimulate both cellular and humoral immune functions in the treated hosts. In addition, silymarin at 100 mg/kg appeared to impact on DTH responses and lymphoproliferation. Based on the finding here, it would seem that silymarin has efficient immunostimulant properties. As a recommendation, the application of silymarin along with acupuncture technique (herbal acupuncture) can be thought as a good plan to modulate and enhance the immune system for the management of several immunodeficiency disorders. However, further studies are required to demonstrate this hypothesis.

Acute and Subacute Oral Toxicity Evaluation of Crude Antifungal Compounds Produced by Lactobacillus plantarum HD1 in Rats

  • Son, Hee-Kyoung;Chang, Hae-Choon;Lee, Jae-Joon
    • Preventive Nutrition and Food Science
    • /
    • 제20권3호
    • /
    • pp.190-197
    • /
    • 2015
  • The aim of this study was to investigate the acute and subacute oral toxicity of crude antifungal compounds produced by Lactobacillus plantarum HD1 in Sprague-Dawley rats. In the acute toxicity study, the crude antifungal compounds (0.625, 1.25, 2.5, and 5.0 g/kg) did not produce mortality, significant changes in general behavior, or changes in the gross appearance of the organs. In the subacute toxicity study, the crude antifungal compounds were administered orally to rats at doses of 0, 0.5, 1.0, and 2.0 g/kg daily for 28 days. There were no test article-related deaths, abnormal clinical signs, or body weight changes. The study also showed no significant differences between the control and treated groups in hematological and serum biochemical parameters, histopathological examination, or any other findings. These results suggest that acute or subacute oral administration of crude antifungal compounds from L. plantarum HD1 is not toxic in rats.

중크롬산 유발 급성신부전증에 미치는 홍삼 $S_I$-분획의 효과 (The Protective Effect of Red Ginseng $S_I-fraction$ against Dichromate-Induced Acute Renal Failure)

  • 나기정;강규상;김은
    • 고려인삼학회:학술대회논문집
    • /
    • 고려인삼학회 1988년도 학술대회지
    • /
    • pp.43-46
    • /
    • 1988
  • 홍삼 $S_I$-분획의 투여로 중크롬산에 의한 신장세포독성이 감소되었다. 토끼에 중크롬산을 투여하면 급성신부전이 유발되어 10일이내에 대부분이 죽었다. 반면 홍삼 $S_I$-분획을 투여하면 치사율이 상당히 낮아졌으며, 생리적 증상이 현저히 개선되었다. 홍삼 $S_I$-분획의 투여로 중크롬산에 의하여 생기는 glomerulotubular imbalance가 호전되었으며, 당원생성, 해당속도, 젖산 생성속도가 정상화 되었다. 홍삼 $S_I$-분획의 효과는 비타민 C, EDTA, 휴로세마이드에 비하여 월등하였다.

  • PDF

사료 첨가제에 의한 대하의 혈액학적 특성 (Hematological Characterization of Penaeus chinensis by Feed-additives)

  • 김영진;이선이;조효진;유선녕;김광연;최원철;허문수;안순철
    • 생명과학회지
    • /
    • 제16권7호
    • /
    • pp.1087-1089
    • /
    • 2006
  • Shrimp has efficient non-specific defense mechanisms based on activities of the hemocytes against pathogens. Up to now, it has been known that one of the non-specific immune reactions is related to mutual association among types of hemocyte, granular cell, semi-granular cell, and hyaline cell. In this study, we tried to know the effectiveness of feed-additives such as 5-aminolevulinic acid(ALA), chitosan, and hot-water extract of herb on immunity of shrimp (Penaeus chinensis) by hemocytic observation and SDS-PAGE analysis. Finally, we suggest a principle of the examination system for effects of various feed-additives.

랫드에서 인체 재조합 적혈구 조혈인자, rHu-EPO의 아급성정맥독성시험 (Subacute Intravenous Toxicity Study of Recombinant Human Erythropoietin(rHu-EPO) in Rats)

  • 김형식;곽승준;천선아;임소영;박현선;홍채영;김원배;김병문;안병옥
    • Toxicological Research
    • /
    • 제12권2호
    • /
    • pp.309-318
    • /
    • 1996
  • This study was conducted to investigate the subacute intravenous toxicity of rHu-EPO in Sprague-Dawley rats. rHu-EPO was daily administered to male and female rats for 30 days with different dose levels(100, 500, 2,500 unit/ kg). After the administration period of 30 days, 5 males and 5females rats per each dose group were assigned for recovery period of additional 30 days. There were no clinical signs compared with control group but slight decrease in spontaneous motor activities and locomotions were observed at high dose groups of males and females. In males, feed consumption was reduced at 500 unit/kg and body weight gain was retarded. In the administration sites of tail, focal congestion was observed in a few animals treated with rHu-EPO. No deaths were occurred during the course of study. In hematological examination. a significant increase of hemoglobin and hematocrit was observed in the males and females rats receiving high dose of rHu-EPO. rHu-EPO administration for 30 days showed a marked decrease in glucose concentration. At the highest dose groups, there was a significant incerase in the weights of spleens in both sexes. but this was considered to be related to its pharmacological activity. These results indicate that rHu-EPO does not induce any significant toxic effect on Sprague-Dawley rats for 30 days.

  • PDF

비글개에서 인체 재조합 적혈구 조혈인자, rHu-EPO의 급성독성에 관한 연구 (Acute Toxicity of Recombinant Human Erythropoietin (rHu-EPO) in Beagle Dogs)

  • 조명행;성하정;김형식;곽승준;천선아;임소영;김원배;김병문;안병옥;이병무
    • Toxicological Research
    • /
    • 제12권2호
    • /
    • pp.305-308
    • /
    • 1996
  • The acute toxicity of rHu-EPO, newly developed recombinant erythropoietin, was tested in beagle dogs. rHu-EPO, when administered intravenously at 25, 000 IU/kg, did not cause any death. Also, rHu-EPO did not induce any change of body weight, food intake and clinical signs compared to controls. There were no significant changes in hematological, urine analysis and pathological examination. These results showed that rHu-EPO did not induce any remarkable toxic response and the $LD_50$ was greater than 25, 000 IU/kg in beagle dogs.

  • PDF

Four-Week Repeated Oral Toxicity Study of AIP1, a Water-soluble Carbohydrate Fraction from Artemisia iwayomogi in Mice

  • Ryu, Sung-Ha;Jo, Hae-Ran;Kim, Ji-Won;Youn, Hyun-Joo;Kim, Kyu-Bong
    • Toxicological Research
    • /
    • 제27권4호
    • /
    • pp.261-267
    • /
    • 2011
  • Artemisia iwayomogi, a member of the Compositae, is a perennial herb easily found in Korea and used as a traditional medicine to treat liver disease. AIP1, a water-soluble carbohydrate fraction from Artemisia iwayomogi, showed anti-tumor and immuno-modulating activities in animal studies. A subacute toxicological evaluation of AIP1 was performed for 4 weeks in ICR mice. After administration of AIP1 (0, 20, 100, 500 mg/kg/day), the clinical signs, mortalities, body weight changes, hematology, blood clinical biochemistry, urinalysis, organ histopathology, organ weights and gross finding were examined. The results showed that there were no significant differences in body weight changes, food intakes, water consumptions, or organ weights among different dose groups. Also we observed no death and abnormal clinical signs during the experimental period. Between the groups orally treated with AIP1 and the control group, there was no statistical significance in hematological test or serum biochemical values. Histopathological examination showed no abnormal changes in AIP1 groups. These results suggest that no observed adverse effect level (NOAEL) of the oral administration of AIP1 for 4 weeks was considered to be more than 500 mg/kg/day in mice under the condition investigated in current study.

Thirteen-Week Oral Dose Toxicity Study of G. bimaculatus in Sprague-Dawley Rats

  • Ahn, Mi-Young;Han, Jea-Woong;Kim, Soon-Ja;Hwang, Jae-Sam;Yun, Eun-Young
    • Toxicological Research
    • /
    • 제27권4호
    • /
    • pp.231-240
    • /
    • 2011
  • Gryllus bimaculatus (Gb) was orally administered at doses of 0, 0.04, 0.2, 1 and 5 g/kg bw/day for 13 consecutive weeks. There were no observed clinical signs or deaths related to treatment in all the groups tested. Therefore, the approximate lethal oral dose of G. bimaculatus was considered to be higher than 5 g/kg in rats. Throughout the administration period, no significant changes in diet consumption, ophthalmologic findings, organ weight, clinical pathology (hematology, clinical chemistry, coagulation, and urinalysis) or gross pathology were detected. Minor changes were found in hematological parameters for the 5 g/kg Gb-treated group (triglyceride reduction of 35.8%), but all changes were within normal physiological ranges. Microscopic examination did not identify any treatment-related histopathologic changes in the organs of Gb-treated rats in the high dose group. From these results, one can conclude that the no-observed adverse effect level (NOAEL) of G. bimaculatus is higher than 5 g/kg bw/day in rats.